How do new range of DMTs available that reduce relapse rate affect disease progression?

In this video Chris interviews Professor Alan Thompson who is a Neurologist. The interview was filmed by Henry

Video transcript

Chris asks Professor Alan Thompson about the disease modifying treatments affect disease progression.

MS Reporter: Chris

MS Expert: Professor Alan Thompson is the Dean of UCL Brain Science and leads a research programme in neuroscience for UCL Partners. He is interested in progressive MS.

More videos about Which DMT category

Leave a Reply

Got a question? Ask an expert.
Join the Shift.ms communityclose